These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10688806)

  • 1. Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable.
    Kogan SC; Hong SH; Shultz DB; Privalsky ML; Bishop JM
    Blood; 2000 Mar; 95(5):1541-50. PubMed ID: 10688806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.
    Brown D; Kogan S; Lagasse E; Weissman I; Alcalay M; Pelicci PG; Atwater S; Bishop JM
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2551-6. PubMed ID: 9122233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia.
    Kogan SC; Brown DE; Shultz DB; Truong BT; Lallemand-Breitenbach V; Guillemin MC; Lagasse E; Weissman IL; Bishop JM
    J Exp Med; 2001 Feb; 193(4):531-43. PubMed ID: 11181704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies.
    Ablain J; Leiva M; Peres L; Fonsart J; Anthony E; de Thé H
    J Exp Med; 2013 Apr; 210(4):647-53. PubMed ID: 23509325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
    Agadir A; Cornic M; Gourmel B; Lefebvre P; Degos L; Chomienne C
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):263-74. PubMed ID: 7920173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
    Benedetti L; Grignani F; Scicchitano BM; Jetten AM; Diverio D; Lo Coco F; Avvisati G; Gambacorti-Passerini C; Adamo S; Levin AA; Pelicci PG; Nervi C
    Blood; 1996 Mar; 87(5):1939-50. PubMed ID: 8634442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein.
    Nervi C; Ferrara FF; Fanelli M; Rippo MR; Tomassini B; Ferrucci PF; Ruthardt M; Gelmetti V; Gambacorti-Passerini C; Diverio D; Grignani F; Pelicci PG; Testi R
    Blood; 1998 Oct; 92(7):2244-51. PubMed ID: 9746761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
    Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
    Shao W; Benedetti L; Lamph WW; Nervi C; Miller WH
    Blood; 1997 Jun; 89(12):4282-9. PubMed ID: 9192750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.
    Schoofs T; Rohde C; Hebestreit K; Klein HU; Göllner S; Schulze I; Lerdrup M; Dietrich N; Agrawal-Singh S; Witten A; Stoll M; Lengfelder E; Hofmann WK; Schlenke P; Büchner T; Hansen K; Berdel WE; Rosenbauer F; Dugas M; Müller-Tidow C
    Blood; 2013 Jan; 121(1):178-87. PubMed ID: 23152544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes.
    Du C; Redner RL; Cooke MP; Lavau C
    Blood; 1999 Jul; 94(2):793-802. PubMed ID: 10397747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
    Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular biology of acute promyelocytic leukemia.
    Slack JL; Gallagher RE
    Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
    Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
    Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.
    Sohal J; Phan VT; Chan PV; Davis EM; Patel B; Kelly LM; Abrams TJ; O'Farrell AM; Gilliland DG; Le Beau MM; Kogan SC
    Blood; 2003 Apr; 101(8):3188-97. PubMed ID: 12515727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D; Solomon E
    Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.
    Grignani F; Gelmetti V; Fanelli M; Rogaia D; De Matteis S; Ferrara FF; Bonci D; Grignani F; Nervi C; Pelicci PG
    Oncogene; 1999 Nov; 18(46):6313-21. PubMed ID: 10597230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
    Orfali N; O'Donovan TR; Cahill MR; Benjamin D; Nanus DM; McKenna SL; Gudas LJ; Mongan NP
    Eur J Haematol; 2020 Mar; 104(3):236-250. PubMed ID: 31811682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.
    Benedetti L; Levin AA; Scicchitano BM; Grignani F; Allenby G; Diverio D; Lo Coco F; Avvisati G; Ruthardt M; Adamo S; Pelicci PG; Nervi C
    Blood; 1997 Aug; 90(3):1175-85. PubMed ID: 9242550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.